Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

56.5%

% of XDNA's 23 holdings also in GNOM

31.7%

% of GNOM's 41 holdings also in XDNA

Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XDNA
Weight
in GNOM
Overlap
CRISPR THERAPEUTICS AG 15.1% 5.8% 5.8%
INTELLIA THERAPEUTICS, INC. 8.7% 4.0% 4.0%
BEAM THERAPEUTICS, INC. 13.7% 3.6% 3.6%
AGILENT TECHNOLOGIES INC 2.7% 3.9% 2.7%
EDITAS MEDICINE, INC. 5.7% 1.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
BEAM THERAPEUTICS, INC. 10.1%
THERMO FISHER SCIENTIFIC INC 9.5%
CRISPR THERAPEUTICS AG 9.3%
PRIME MEDICINE, INC. 5.9%
INTELLIA THERAPEUTICS, INC. 4.7%
EDITAS MEDICINE, INC. 4.2%
CARIBOU BIOSCIENCES, INC. 3.9%
ABBVIE INC 3.8%
POSEIDA THERAPEUTICS, INC. 3.8%
VERVE THERAPEUTICS, INC. 3.6%
XDNA Underweight Relative to GNOM
ENI SPA-SPONSORED ADR -7.5%
NATERA INC -4.4%
ARROWHEAD PHARMACEUTICALS, INC. -3.9%
10X GENOMICS INC CLASS A -3.8%
ULTRAGENYX PHARMACEUTICAL IN -3.8%
GENSCRIPT BIOTECH CORPORATION -3.7%
PACIFIC BIOSCIENCES OF CALIF -3.7%
BIOMARIN PHARMACEUTICAL INC -3.5%
VERACYTE INC -3.4%
BIO-TECHNE CORPORATION -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY